Market Access & Pricing Lead KSA

About the role

Galderma, a dermatology company active in about 90 countries, is looking for a Market Access & Pricing Lead based in Riyadh, Saudi Arabia. The role owns the national market access, pricing and reimbursement strategy for the Saudi portfolio, from pre-launch planning through post-launch optimisation, institutional tenders and stakeholder engagement.

Key responsibilities

• Build and own the national market access, pricing and reimbursement strategy, translating it into plans for clusters, accounts, tenders and stakeholders, and manage price positioning within the international reference system
• Design access solutions such as managed entry, outcomes-based and risk-sharing agreements and patient access programmes
• In the 6-12 months before launch: map stakeholders, align with Medical Affairs and Regulatory Affairs on SFDA registration, define price corridors and lead pricing submissions
• Post-launch: drive listing on the Ministry of Health and institutional formularies, secure Council of Health Insurance coverage and manage price re-evaluations and loss-of-exclusivity planning
• Own the national tender strategy for NUPCO, long-term agreements and direct institutional purchases, including local-content compliance and contracting terms
• Lead HEOR, budget impact and cost-effectiveness work, and negotiate pricing and reimbursement with SFDA, NUPCO, the Ministry of Health and institutional payers
• Engage with regulators, health clusters, payers and key opinion leaders, and monitor policy changes
• Represent access on the Country Leadership Team and act as the in-country point of contact for regional and global pricing committees

Required profile

• Bachelor's degree in Pharmacy, Life Sciences, Health Economics or a related field; MBA, MPH or Master's in Health Economics preferred
• 12+ years in pharma or biopharma, including 5+ years in market access, pricing or institutional business at national level in Saudi Arabia
• Proven record of at least two successful launches with secured SFDA price and national listing, plus post-launch access and tender gains
• Fluent spoken and written English and Arabic; Saudi nationality is mandatory
• Advantage: immunology, specialty, oncology, rare disease or biologics experience

Required skills

• Hands-on experience with SFDA pricing, NUPCO and MOH tenders, institutional formulary and P&T processes, and payer negotiations
• HEOR, budget impact and cost-effectiveness modelling